News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Manas Dubey: SOFT (Suppression of Ovarian Function Trial) and TEXT (Tamoxifen and Exemestane Trial) Clinical Trials
Photo: Depositphotos
May 25, 2025, 08:11

Manas Dubey: SOFT (Suppression of Ovarian Function Trial) and TEXT (Tamoxifen and Exemestane Trial) Clinical Trials

Manas Dubey, Medical Oncologist and Hemat-Oncologist at Kamla Nehru Memorial Hospital, posted on X:

“SOFT (Suppression of Ovarian Function Trial) and TEXT (Tamoxifen and Exemestane Trial), two landmark clinical trials.
Results:
12-year DFS rates –
Tamoxifen alone (67.0%), Tamoxifen + Ovarian Function Suppression (OFS) (70.5%), and Exemestane + OFS (73.5%).”

Manas Dubey: SOFT (Suppression of Ovarian Function Trial) and TEXT (Tamoxifen and Exemestane Trial) Clinical Trials

More posts featuring Breast Cancer.

Breast Cancer cancer Manas Dubey OncoDaily Oncology SOFT TEXT
Special Coverage
Blog
May 25, 2025, 08:11
Manas Dubey: SOFT (Suppression of Ovarian Function Trial) and TEXT (Tamoxifen and Exemestane Trial) Clinical Trials
Blog
May 25, 2025, 07:43
Lao Saal Recaps 7th Swedish Cancer Research Meeting and Showcases Top Talks
Blog
May 25, 2025, 07:04
Wafaa M Rashed: U.S. MAHA Report Lacks Scientific Insight on Childhood Cancer
Science
May 25, 2025, 06:47
Akhil Kapoor: Triple Oral Metronomic Chemotherapy vs Chemotherapy of Physician Discretion After Failure of Platinum-Based Therapy in HNSCC
Dialogues
May 25, 2025, 06:33
Mikhail Grubman on Building Eastern Europe’s Leading CRO and Accelerating Global Oncology Trials
Opinion
May 25, 2025, 06:32
Anastasia Conti Announces Open Research Positions at SR-Tiget in Milan
Blog
May 25, 2025, 06:24
Bernard Fox: TIMO2025 - Great line-up of Immunotherapy Experts
Blog
May 25, 2025, 06:14
Servier's Patients and Doctors Partnership Symposium
Dialogues
May 25, 2025, 06:08
Beyond the Cancer Diagnosis: Dialogue with Wendy Lichtenthal, by Adrian Pogacian
Blog
May 25, 2025, 06:05
International Myeloma Foundation - The Myeloma Minute is Out!
Blog
May 25, 2025, 06:00
The Lancet - A Call to Action: Second Lancet Commission on Adolescent Health and Wellbeing
Blog
May 25, 2025, 05:51
Mark Tyson: Urine Tumor DNA Stratifies Recurrence Risk in BCG-Unresponsive NMIBC Treated with Atezolizumab